Serotonin metabolism
Serotonin is one of the monoamine neurotransmitters acted on by monoamine oxidase A. MAOA is only one part of the much larger biological system controlling serotonin signalling.
The MAOA gene encodes monoamine oxidase A, a mitochondrial enzyme involved in breaking down monoamine neurotransmitters including serotonin, norepinephrine and dopamine.
Searches for “MAOA methylation” can mean two different things: inherited variants in the MAOA gene, or epigenetic DNA methylation affecting regulation of the MAOA gene. Understanding that difference is essential before interpreting a genetic report.
MAOA provides instructions for making monoamine oxidase A. The enzyme helps metabolize monoamines through oxidative deamination and is part of the broader system the body uses to process several neurotransmitters and other biologically active amines.
Serotonin is one of the monoamine neurotransmitters acted on by monoamine oxidase A. MAOA is only one part of the much larger biological system controlling serotonin signalling.
MAOA also contributes to norepinephrine breakdown. A genetic result does not directly tell you how much norepinephrine is present in your nervous system.
Dopamine can also be metabolized through monoamine oxidase pathways. Other enzymes and biological processes contribute to dopamine synthesis, transport, signalling and breakdown.
Quick answer: MAOA helps encode an enzyme involved in breaking down several monoamine neurotransmitters. A genetic MAOA result can provide inherited DNA information, but it does not directly measure your serotonin, dopamine or norepinephrine levels.
This search term is easy to misunderstand because “methylation” can refer either to a broader consumer methylation-gene discussion or to actual epigenetic methyl marks measured on DNA.
Genetic testing examines inherited DNA sequence differences. These variants are part of your genotype and are generally stable throughout life.
A genetic wellness report may discuss MAOA alongside COMT and other genes related to neurotransmitter and methylation-associated pathways.
Epigenetic methylation refers to chemical methyl marks associated with DNA regulation. Research has examined methylation within the MAOA promoter region in relation to gene regulation.
That is a different measurement from simply identifying an inherited MAOA SNP or repeat variant.
Key distinction: If a consumer DNA report lists an MAOA genotype, that does not mean the test has measured the methylation level of the MAOA promoter. Genetic sequence testing and epigenetic DNA methylation testing use different biological measurements.
MAOA should be understood as one enzyme within a network rather than as a single switch controlling mood, stress response or neurotransmitter concentrations.
Researchers have studied several forms of variation around the MAOA gene. One frequently discussed regulatory variant is the MAOA-uVNTR, a variable number tandem repeat located in a regulatory region of the gene.
Laboratory and human research has investigated whether different repeat patterns can affect MAOA transcription or enzyme-related biology. That does not make the variant a stand-alone predictor of personality, mental health, aggression or behaviour.
If a test reports an MAOA variant, first confirm exactly which variant or marker was analyzed. Different tests do not necessarily examine the same MAOA markers.
An MAOA result can provide information about inherited genetic variation when the relevant marker is included in the test. Its limitations are just as important as the result itself.
Labels that reduce MAOA to a “warrior gene,” aggression gene or personality gene oversimplify complex research.
Behavioural and mental-health traits develop through interactions among many genes, development, environment, experiences, health and other biological factors. One MAOA variant is not a deterministic behavioural test.
A statistical association observed in a research population does not mean everyone carrying a particular MAOA variant will show the same trait.
Research on complex behavioural outcomes often examines interactions among genetic, developmental and environmental factors rather than treating one gene as a complete explanation.
A responsible report should explain MAOA biology without turning a genotype into a prediction of aggression, personality or mental health.
MAOA and COMT are often discussed together because both participate in neurotransmitter metabolism, but they use different biochemical mechanisms.
Monoamine oxidase A participates in oxidative deamination of monoamines including serotonin, norepinephrine and dopamine.
MAOA is therefore primarily discussed in the context of monoamine breakdown and regulation.
Catechol-O-methyltransferase uses a methyl group from S-adenosylmethionine to methylate catechol compounds, including catecholamine substrates.
COMT therefore has a more direct biochemical connection to a methyl-transfer reaction.
Why the distinction matters: MAOA should not be described as performing the same methyl-transfer reaction as COMT. MAOA is relevant to a broader methylation-focused genetic report because pathways overlap, but the enzymes perform different biochemical jobs.
Researchers have examined DNA methylation patterns in regulatory regions of MAOA because epigenetic marks can be associated with gene regulation.
Studies in particular populations have reported associations between MAOA promoter methylation, gene expression and selected clinical or behavioural measures. However, findings vary by study design, population, tissue and methylation site.
Importantly, research examining MAOA DNA methylation and brain MAO-A protein availability has not established a simple one-to-one relationship that could be used as a universal consumer interpretation rule.
Neurotransmitter metabolism and one-carbon biology involve many genes, enzymes and regulatory systems. Looking at MAOA alone can make the biology appear much simpler than it is.
A gene-by-gene library can help separate each enzyme's role while also showing how different pathways connect.
Participates in catecholamine metabolism through a methyl-transfer reaction that uses SAM.
Functions in folate metabolism and helps support the folate-dependent side of one-carbon metabolism.
Encodes methionine synthase and participates in remethylation of homocysteine to methionine.
Helps maintain methionine synthase activity within the vitamin-B12-linked remethylation pathway.
If MAOA is one reason you are considering a genetic test, verify the product's actual gene and variant coverage rather than assuming that all methylation tests analyze the same MAOA markers.
Check which MAOA SNP, repeat variant or other marker the test actually reports.
Use the sample report to see whether results are explained with biological context and appropriate limitations.
Review whether the test includes other relevant genes rather than relying on one MAOA result as the complete explanation.
MAOA biology does not change by state or city, so local SEO should not imply that the gene itself works differently in New York, California, Texas or another location.
The practical U.S. differences are ordering eligibility, kit delivery, sample-return logistics and access to support. Review current U.S. shipping information, testing locations and the testing workflow before ordering.
Confirm current ordering eligibility and shipping information for your location before purchasing.
Review the required sample, preparation instructions, packaging and return process before collecting.
Confirm whether you are receiving inherited genetic information, epigenetic measurements or another type of laboratory result.
This page separates established gene function from emerging or population-specific findings. Primary and authoritative biomedical sources should be reviewed when interpreting MAOA biology.
Direct answers about MAOA methylation, neurotransmitters, genetic variants, promoter methylation and DNA testing.
MAOA stands for monoamine oxidase A. The MAOA gene provides instructions for making an enzyme involved in breaking down monoamine compounds.
Monoamine oxidase A participates in metabolism of monoamines including serotonin, norepinephrine and dopamine. Other enzymes, transporters and regulatory systems also influence these neurotransmitters.
It can refer specifically to epigenetic methyl marks in regulatory regions of the MAOA gene. That is different from testing inherited MAOA DNA sequence variants.
No. A genetic variant is an inherited DNA sequence difference. DNA methylation is an epigenetic modification associated with gene regulation. They require different types of interpretation.
No. An MAOA genotype does not directly measure serotonin, dopamine or norepinephrine concentrations in the brain or blood.
MAOA-uVNTR is a variable number tandem repeat in a regulatory region of MAOA that has been studied for potential effects on gene transcription. It should not be treated as a stand-alone behavioural or medical prediction.
That label is an oversimplification. Complex behaviours and mental-health outcomes cannot be predicted reliably from one MAOA variant because genetic, developmental, environmental and other biological factors interact.
No. A consumer MAOA genetic result does not diagnose a psychiatric or neurological condition. Clinical concerns require appropriate evaluation by a qualified healthcare professional.
Broader context is more useful than relying on one gene. The exact variant, related genes, medical history, medications, environment and other relevant information can all affect interpretation.
Scientific context reviewed August 20, 2026. Gene interpretation and testing specifications should be rechecked as evidence and products evolve.
MAOA provides one piece of a much larger genetic and biological picture. If you are considering DNA testing, compare gene coverage, report clarity and interpretation limits before choosing an option.
Understand what the result measures before deciding what it means.